Feeling the heat of the bear market, eye disease biotech to implement 'expense streamlining' plan and lay off 50

The company behind an FDA-approved inhalable form of smoking cessation aid Chantix for dry eye disease is falling in line with quite a few other …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Feel­ing the heat of the bear mar­ket, eye dis­ease biotech to im­ple­ment 'ex­pense stream­lin­ing' plan and lay off 50